Extrawell Pharmaceutical Holdings (HKSE:00858) EV-to-EBIT : -0.83 (As of May. 25, 2024)

Extrawell Pharmaceutical Holdings EV-to-EBIT Chart

Extrawell Pharmaceutical Holdings Annual Data
	Trend	Mar14	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23
EV-to-EBIT		Get a 7-Day Free Trial					2.20	1.57	-2.92	1.23	1.09

Extrawell Pharmaceutical Holdings Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
EV-to-EBIT	Get a 7-Day Free Trial															-	1.23	-	1.09	-

Competitive Comparison of Extrawell Pharmaceutical Holdings's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Extrawell Pharmaceutical Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Extrawell Pharmaceutical Holdings's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Extrawell Pharmaceutical Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Extrawell Pharmaceutical Holdings's EV-to-EBIT falls into.

Extrawell Pharmaceutical Holdings EV-to-EBIT Calculation

Extrawell Pharmaceutical Holdings's EV-to-EBIT for today is calculated as:

Extrawell Pharmaceutical Holdings's current Enterprise Value is HK$110.68 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Extrawell Pharmaceutical Holdings's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was HK$-133.89 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Extrawell Pharmaceutical Holdings  (HKSE:00858) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Extrawell Pharmaceutical Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

Extrawell Pharmaceutical Holdings's Enterprise Value for the quarter that ended in Sep. 2023 was HK$135.79 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Extrawell Pharmaceutical Holdings's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was HK$-133.89 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Extrawell Pharmaceutical Holdings EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Extrawell Pharmaceutical Holdings's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Extrawell Pharmaceutical Holdings (HKSE:00858) Business Description